FDA approved Lenvima (lenvatinib), a kinase inhibitor, for progressive differentiated thyroid cancer that has kept advancing despite radioactive iodine therapy. The agency used priority review and granted orphan designation; efficacy came from a trial of 392 patients.
Section archive
Page 4 of 63
Drug
Prescription drugs, vaccines and their risks and benefits.
- All desks
- Abortion
- Accutane
- Acetaminophen
- Acid Reflux
- Acidic Foods
- Acne
- Acrylamide
- Acupuncture
- Additives
- ADHD
- Adiposity
- Advisories
- Aerobic Exercise
- Aflatoxin
- Agave
- Agent Orange
- Aging
- Agriculture
- AIDS
- Air Pollution
- Airline Passengers
- Airport
- ALA
- Alcohol
- Alcoholic Beverage
- Alerts
- Allergy
- Alli
- Aloe Vera
- ALS
- Alternative Medicine
- Aluminum
- Alzheimer's
- Amalgam
- AMD
- Ampyra
- Amygdala
- Anal Cancer
- And
- Anemia
- Angiogenesis
- Animal Protein
- Animals
- Anorexia
- Anthocyanins
- Anthrax
- Anti-Angiogenesis
- Anti-Obesity
- Antibacterial
- Antibiotic
Drug
Ibuprofen linked to increased libido, erectile function
A case report in the Journal of International Oral Health describes a 26-year-old man in Saudi Arabia who reported increased libido and erectile function after taking ibuprofen for dental pain. The authors call the effect rarely reported and could not explain why it happened.
Drug
FDA okays Vyvanse for treatment of binge-eating disorder
The FDA approved Vyvanse for binge-eating disorder in adults, the first drug cleared for the condition. In two studies of 724 adults with moderate-to-severe disease, those taking it had fewer binge eating days per week than the comparison group.
Drug
Pancreatic Cancer: Targeted Treatments Hold Promise
The FDA notes it has approved three treatments for advanced pancreatic cancer in 20 years - gemcitabine, erlotinib with gemcitabine, and nab-paclitaxel with gemcitabine - and that KRAS is mutated in most tumor samples. The cancer is the fourth leading cause of US cancer death.
Drug
FDA approves first generic esomeprazole
FDA approved the first generic Nexium, esomeprazole magnesium delayed-release capsules, for treating GERD in adults and children aged 1 and older. Ivax Pharmaceuticals, a Teva subsidiary, will market the 20 and 40 milligram capsules.
Drug
Opioid painkillers widely prescribed among reproductive age women
A CDC report in MMWR found that each year from 2008 to 2012, an average 39 percent of Medicaid-enrolled women aged 15 to 44 and 28 percent of privately insured women filled an opioid prescription, most often hydrocodone, codeine or oxycodone.
Drug
Influenza Vaccine for This Year Does not Work as Thought
Barbara Loe Fisher writes that the CDC put flu vaccine effectiveness at 47 to 62 percent over three seasons while some experts measured 0 to 7 percent, and that this year's shot does not protect against the most common influenza A subtype now making people sick.
Drug
The Forgotten History of Vaccinations You Need to Be Aware Of
Mercola recommends Dr. Suzanne Humphries' book Dissolving Illusions, which argues smallpox was eradicated through isolation, better nutrition, hygiene and sanitation, and that polio counts fell largely because the disease was redefined and serological testing introduced.
Drug
Many Americans at risk for alcohol-medication interactions
An NIAAA study estimates that nearly 42% of US adults who drink also take medications known to interact with alcohol, rising to almost 78% among drinkers over 65. Effects range from nausea and poor coordination to internal bleeding and heart problems.
Drug
Efficacy of flu vaccine for this year is 23%, how can we do to prevent flu then?
CDC's interim estimate, drawn from 2,321 children and adults enrolled between November 10, 2014 and January 2, 2015, puts flu vaccine effectiveness against medically attended illness at 23 percent, with a confidence interval of 8 to 36 percent. Most infections were A(H3N2).
Drug
FDA MedWatch - December 2014 Safety Labeling Changes posting includes 72 products with changes to Prescribing Information
FDA's MedWatch posting for December 2014 lists 72 products with revisions to boxed warnings, contraindications, warnings, precautions, adverse reactions or patient package inserts, among them Abilify, Nexium, Micardis, Geodon, Jakafi and Kalydeco.
Drug
Updates on Ebola and Ozone Therapy
Dr. Robert Rowen tells Mercola what happened after he and Dr. Howard Robins flew to Sierra Leone in October, at the president's invitation, to teach health workers to treat Ebola with ozone. Rowen argues ozone inactivates viruses and carries almost no toxicity.
Drug
FDA approves weight-management drug Saxenda
FDA approved liraglutide injection for chronic weight management alongside a reduced-calorie diet and exercise, in adults with a BMI of 30 or more, or 27 or more plus a condition such as hypertension, type 2 diabetes or high cholesterol. It must not be combined with Victoza.
Drug
FDA approves Lynparza to treat advanced ovarian cancer
The FDA granted accelerated approval to Lynparza (olaparib), a PARP inhibitor for women with heavily pretreated advanced ovarian cancer tied to defective BRCA genes, alongside the BRACAnalysis CDx companion test that detects those mutations in blood samples.
Drug
Pharmaceutical Industry Expects to create 45000 more jobs in India in 2015
A press release on IIHMR University's national seminar in Jaipur, where pharmaceutical industry figures discussed India's projected growth to $55 billion by 2020, the pull of Tier-I and rural markets, and the need for closer links between pharma education and industry.
Drug
Lanreotide
FDA approved the injection for unresectable, well or moderately differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors. In a 204-patient placebo-controlled trial, median progression-free survival passed 22 months against 16.6 on placebo.
Drug
FDA MedWatch - 0.9 Percent Sodium Chloride Injection USP in 100 mL MINI-BAG PLUS Container by Baxter: Recall - Particulate Matter
Baxter recalled two lots of 0.9 percent sodium chloride injection in 100 mL Mini-Bag Plus containers after two complaints of particulate matter traced to a fragment of the vial adapter. Lots P317842 and P317891 should not be used.
Drug
Barrier-breaking drug may lead to spinal cord inury treatments
NIH-funded researchers report in Nature that injections of a new drug partly relieved paralysis in rats with spinal cord injuries. Case Western's Jerry Silver calls it a first step toward therapies that might restore movement lost to such injuries.
1120 stories